The invention relates to a multilayer flexible material (of a tape type) which can be applied and adhere onto a surface to modify its properties. Particularly, an antibacterial and/or antiviral multilayers material comprising a tie binding layer with at least one adhesive face arranged to be fixed on any suitable surface and an active treatment layer arranged on the face of the tie binding layer opposite to adhesive face, said treatment layer comprising anti-bacterial and/or anti-viral agents. The invention is also related to an associated application method and specific uses.

The invention relates to a multilayer flexible material (of a tape type) which can be applied and adhere onto a surface to modify its properties. Particularly, an antibacterial and/or antiviral multilayers material comprising a tie binding layer with at least one adhesive face arranged to be fixed on any suitable surface and an active treatment layer arranged on the face of the tie binding layer opposite to adhesive face, said treatment layer comprising anti-bacterial and/or anti-viral agents. The invention is also related to an associated application method and specific uses.

This invention is referred to the field of medicine, namely preventative treatment, and may be used as a means of synergetic minimization of negative impact of flights on human health (brain, stomach, lungs, blood vessels, heart etc.) with application of known substances and medicines with newly discovered pharmacological properties in new conditions. The ultimate technical solution of this invention would be synergetic minimization of negative impact of flying on human health without foot swelling, belching, jet-lag, tiredness and fatigue etc. The claimed technical result is achieved by the method of synergetic minimization of negative impact of air flights on human health, including consumption of substances that improve osmotic concentration of blood plasma, in the form of oral rehydration solution, split into two intakes as a minimum, first intake in the amount of at least 0.3 liters up to 1 liter before boarding and further during the flight from half an hour to 2 hours at least 0.3 liters to 1 liter and on as-needed basis.

This invention is referred to the field of medicine, namely preventative treatment, and may be used as a means of synergetic minimization of negative impact of flights on human health (brain, stomach, lungs, blood vessels, heart etc.) with application of known substances and medicines with newly discovered pharmacological properties in new conditions. The ultimate technical solution of this invention would be synergetic minimization of negative impact of flying on human health without foot swelling, belching, jet-lag, tiredness and fatigue etc. The claimed technical result is achieved by the method of synergetic minimization of negative impact of air flights on human health, including consumption of substances that improve osmotic concentration of blood plasma, in the form of oral rehydration solution, split into two intakes as a minimum, first intake in the amount of at least 0.3 liters up to 1 liter before boarding and further during the flight from half an hour to 2 hours at least 0.3 liters to 1 liter and on as-needed basis.

Oral formulations include anti-viral agents. These oral formulations are manufactured in various permutations such as a chewing gum or lozenge which incorporate anti-viral agents for protecting an individuals body from viruses.

Oral formulations include anti-viral agents. These oral formulations are manufactured in various permutations such as a chewing gum or lozenge which incorporate anti-viral agents for protecting an individuals body from viruses.

Compositions comprising an aqueous medium, lipids and nonionic surfactants and methods of their use in preventing skin damages, such as in subjects exposed to radiation, are provided.

Compositions comprising an aqueous medium, lipids and nonionic surfactants and methods of their use in preventing skin damages, such as in subjects exposed to radiation, are provided.

The present patent application relates a process for the production of compressed tablets using specific coated particles, wherein the coating (system) comprises at least one wax and/or at least one fat. Furthermore it relates to compressed (compacted) tablets and as well as to specific coated particles.

The present patent application relates a process for the production of compressed tablets using specific coated particles, wherein the coating (system) comprises at least one wax and/or at least one fat. Furthermore it relates to compressed (compacted) tablets and as well as to specific coated particles.